NPPN.Y Stock Overview
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Nippon Shinyaku Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥6.84 |
52 Week High | JP¥11.71 |
52 Week Low | JP¥6.84 |
Beta | -0.086 |
1 Month Change | -7.38% |
3 Month Change | n/a |
1 Year Change | -39.51% |
3 Year Change | n/a |
5 Year Change | -61.60% |
Change since IPO | -45.75% |
Recent News & Updates
Recent updates
Shareholder Returns
NPPN.Y | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | -11.3% | -1.5% | -3.2% |
1Y | -39.5% | 9.7% | 19.3% |
Return vs Industry: NPPN.Y underperformed the US Pharmaceuticals industry which returned 9.7% over the past year.
Return vs Market: NPPN.Y underperformed the US Market which returned 19.3% over the past year.
Price Volatility
NPPN.Y volatility | |
---|---|
NPPN.Y Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.8% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NPPN.Y's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine NPPN.Y's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1911 | 2,186 | Toru Nakai | www.nippon-shinyaku.co.jp |
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases.
Nippon Shinyaku Co., Ltd. Fundamentals Summary
NPPN.Y fundamental statistics | |
---|---|
Market cap | US$1.87b |
Earnings (TTM) | US$155.93m |
Revenue (TTM) | US$949.40m |
12.0x
P/E Ratio2.0x
P/S RatioIs NPPN.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NPPN.Y income statement (TTM) | |
---|---|
Revenue | JP¥146.98b |
Cost of Revenue | JP¥52.04b |
Gross Profit | JP¥94.95b |
Other Expenses | JP¥70.81b |
Earnings | JP¥24.14b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 10, 2024
Earnings per share (EPS) | 358.41 |
Gross Margin | 64.60% |
Net Profit Margin | 16.42% |
Debt/Equity Ratio | 0% |
How did NPPN.Y perform over the long term?
See historical performance and comparison